Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together.
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing its pipeline of peptide conjugate therapeutics engineered through its IMP3ACT platform that reduces the complexity of drug development and manufacturing. It is focused on developing effective treatments for patients with cancer with high, unmet medical needs. The company’s lead candidate, seclidemstat (SP-2577), is being studied as treatment for pediatric cancers, sarcomas, and other cancers with limited treatment options. Its pipeline consists of SP-3164 a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. SP-3164 is a next-generation cereblon-binding MG. SP-2577 is a small-molecule LSD1 inhibitor with a novel scaffold. more
| Time Frame | DCOY | S&P500 | |
|---|---|---|---|
| 1-Week Return | 18.1%% | % | 0.92%% |
| 1-Month Return | 18.9%% | % | 0.87%% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| DCOY | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| DCOY | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Decoy Therapeutics Inc (DCOY) share price today is $0.776
Yes, Indians can buy shares of Decoy Therapeutics Inc (DCOY) on Vested. To buy
Yes, you can purchase fractional shares of Decoy Therapeutics Inc (DCOY) via the Vested app. You can start investing in Decoy Therapeutics Inc (DCOY) with a minimum investment of $1.
You can invest in shares of Decoy Therapeutics Inc (DCOY) via Vested in three simple steps:
The 52-week high price of Decoy Therapeutics Inc (DCOY) is $0.9. The 52-week low price of Decoy Therapeutics Inc (DCOY) is $0.51.
The price-to-earnings (P/E) ratio of Decoy Therapeutics Inc (DCOY) is
The price-to-book (P/B) ratio of Decoy Therapeutics Inc (DCOY) is 0.00
The dividend yield of Decoy Therapeutics Inc (DCOY) is 0.00%
The market capitalization of Decoy Therapeutics Inc (DCOY) is
The stock symbol (or ticker) of Decoy Therapeutics Inc is DCOY
Link copied